I-Agent Antiviral Enamandla
I-Ribavirin iyisidakamizwa esinamandla sokulwa namagciwane esetshenziselwa ukuphatha ukutheleleka okungapheli kwesifo se-hepatitis C. Akuqondwa ngokuphelele ukuthi i-ribavirin kodwa, kodwa ngokujwayelekile, iphazamisa ikhono legciwane lokuphindaphinda. I-Ribavirin ivunyiwe yi-Food and Drug Administration (FDA) yokwelapha i-hepatitis C futhi kuyi-World Health Organisation List of Medicine Essential.
I-Ribavirin idayiswa ngaphansi kwenani lamagama ahlukahlukene wegama, kuhlanganise neCopegus, Rebetol, Ribasphere, ne-RibaPak.
Ukusebenza kwezidakamizwa
Ngaphambi kokusungulwa kwama-anti-virus (DAAs) ngokuqondile-ngo-2013-okubandakanya izidakamizwa zeSovaldi , Harvoni , Daklinza neVikira Phak , phakathi kwabanye-indlela ephumelela kakhulu yokwelapha i-hepatitis C yayihlanganisa inhlanganisela ye-ribavirin ne- peginterferon . I-thérapie ezimbili ziyaziwa ukuthi zinezinga eliphakeme lemiphumela yokwelashwa, ezinye zazo zingaba zijulile. Noma kunjalo, ukwelashwa okuhlanganisiwe kwakwazi ukufeza impendulo eqhubekayo ye-virologic (incazelo yempilo yomuthi) kuma-50% wamacala.
Namuhla, nge-DAA entsha yeklasi, ukusebenzisa i-ribavirin kuye kwehla cishe nakuba kushiwo ezinhlobonhlobo ezithile zokwelashwa, ikakhulukazi ngezinkinga ezithile zofuzo ( genotypes ) wegciwane kanye neziguli ezinezokwelapha zangaphutha ngaphambilini kanye / noma isifo esiyinhloko sesibindi.
Ukulawulwa kwezidakamizwa
I-Ribavirin ithathwa ngomlomo, ngokuvamile emazingeni amancane athathwa amahora angu-12 ehlukile. Izinga elijwayelekile lisuka ku-800 mg kuya ku-1,400 mg ngosuku. Udokotela wakho uzonika ukuthi i-ribavirin engayinikeza ngokusekelwe ku-genotype yegciwane lakho, isisindo sakho, nokuthi yiziphi ezinye izidakamizwa ezizophathwa ngokuthelela.
Imiphumela Yokwelashwa Side Side
Imiphumela emibi ye-ribavirin izohluka kusuka komuntu kuya komuntu, nabanye abantu abaphathayo bayoba nemicimbi encane yokugula lapho abanye bezwa izimpawu abazibona bengenakuziphendulela. Imiphumela emibi kakhulu ehambisana nokusetshenziswa kwe-peginterferon yilezi:
- I-anemia (amacala angu-10%)
- Izinwele
- Ukuthukuthela nokukhathazeka
- Ukucindezeleka
- Ukulahleka kwezinwele (alopecia)
- Ukuchithwa
- Ukungalali
- Ubuhlungu obuhlangene (i-arthralgia)
- Ubuhlungu besisu ( myalgia )
- I-Anorexia
- I-Neutropenia
- I-nausea nokuhlanza
- Fever
- Ama-Chills
- Ukukhathala
Iziguli zokwelapha ziyokhuluma ngeRuba Rage, efanekiselwa ukucasula okujwayelekile kanye nokuphulukiswa ngokomzwelo ngokomzwelo. Ngesikhathi leli gama libonisa ukuthi imbangela i-ribavirin, ivame ukuhlotshaniswa ne-peginterferon. Ngezinye izikhathi ama-anti-depressants anqunywe ukuze aphathe lesi simo, ikakhulukazi ezigulini ezinezinkinga ezandulela ukugula ngengqondo.
Izindleko zokwelashwa nokufinyelela
Ukwelashwa okuphelele kwe-ribavirin kungabiza kodwa kodwa, ngenhlanhla, ngama-DAA amasha omusha, ubude besikhathi sokwelapha bufushane kakhulu kunangaphambili. Esikhathini esedlule, kungabiza uhla lwe $ 12,000 ukuze uthole inkambo egcwele. Namuhla, kulindeleke ukuba ukhokhe okungaphezulu kuka-$ 2,500 kwenkambo yezinyanga ezingu-12 no-$ 5,000 kwi-course yezinyanga ezingu-16.
I-medicaid, i-Medicare, nomshuwalense wangasese uyovame ukumboza izindleko ze-interferon lapho ukwelashwa kwe-hepatitis C kuvunywa.
Usizo lwe-co-pay lungasetshenziswa ngumkhiqizi wezidakamizwa iziguli ezifanelekile, kanye nezinhlelo zokusiza isiguli (PAPs) eziguli ezingenayo i-uninsured noma ephansi.
Ukuphikisana kokulashwa
I-Ribavirin ibhekwa njengephephile kubantu abaningi, kodwa kunabantu abathile abalashwa khona. I-Ribavirin kufanele igwenywe ngezimo ezilandelayo:
- Uma ukhulelwe. Ucwaningo lwezokwelapha luye lwabonisa ukuthi i-ribavirin ingabangela ukukhubazeka kokuzalwa komntwana . Abesifazane kufanele babekwe i-ribavirin kuphela uma ukuhlolwa kokukhulelwa ngaphambi kokwelashwa kungalungile. Ukwengeza, izinhlobo ezimbili zokuvimbela ukubeletha zeluleka kokubili owesifazane nomlingani wakhe ngesikhathi sokulashwa kanye nezinyanga eziyisithupha ngemuva kokuqeda ukwelashwa.
- Uma uncelisa.
- Uma unesifo sezinso esiphezulu, isifo senhliziyo esiphuthumayo noma isifo sesibindi esiphezulu.
- Uma une-hepatitis yokuzibulala ngokuzenzakalelayo.
Njalo qiniseka ukuthi udokotela wakho unomlando wakho wezokwelapha ophelele, kufaka phakathi ulwazi mayelana nanoma yikuphi ukutheleleka okungapheli okungenzeka ube nakho (isb., I- HIV , isifo sikashukela) noma yiziphi izinhlelo ozidingayo ukuba ukhulelwe.
Imithombo:
I-Genentech. "I-Copegus: Amaphuzu avelele ekuchazeni ulwazi." Kufinyelelwe kuDisemba 31, 2015.
Merck. "I-Rebetol: Okuvelele kokuchaza ulwazi." Kufinyelelwe kuDisemba 31, 2015.